Workflow
Asure Software(ASUR) - 2025 Q4 - Annual Report
2026-02-26 21:09
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Commission File Number: 1-34522 ASURE SOFTWARE, INC. (Exact name of registrant as specified in its charter) None (Former name, former address and former fiscal year, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: (State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.) Delaware 74-2415696 405 Colorado Street, Suite 1800, Austin, Texas 78701 (Address of princ ...
Freshworks(FRSH) - 2025 Q4 - Annual Report
2026-02-26 21:09
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40806 __________________________________________ Freshworks Inc. __________________________________________ FORM 10-K _______ ...
Fidus Investment (FDUS) - 2025 Q4 - Annual Report
2026-02-26 21:09
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00861 FIDUS INVESTMENT CORPORATION (Exact Name of Registrant as Specified in Its Charter) Maryland 27-5017321 (State or Other Jurisdicti ...
Organogenesis (ORGO) - 2025 Q4 - Annual Results
2026-02-26 21:09
Exhibit 99.1 FOR IMMEDIATE RELEASE Organogenesis Holdings Inc. Reports Fourth Quarter 2025 Financial Results, Posts Record Revenue CANTON, Mass., (February 26, 2026) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, manufacturing, and sale of products for the advanced wound care, and surgical and sports medicine markets, today reported financial results for the fourth quarter and the year ended ...
Ironwood(IRWD) - 2025 Q4 - Annual Report
2026-02-26 21:09
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34620 IRONWOOD PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware (State or othe ...
Rocket Lab USA(RKLB) - 2025 Q4 - Annual Results
2026-02-26 21:09
MEDIA RELEASE Rocket Lab founder and CEO, Sir Peter Beck, said: "2026 was a record-breaking year for Rocket Lab financially and operationally. We delivered record quarterly revenue of $180 million, which brought our full year revenue to a record $602 million, representing 38% growth year on year. We reached a new annual launch record, flying 21 missions across Electron and HASTE with a 100% success rate for the year, and also reached significant qualification milestones in the development of Neutron, our ne ...
Teknova(TKNO) - 2025 Q4 - Annual Results
2026-02-26 21:08
Exhibit 99.1 Teknova Reports Fourth Quarter and Full Year 2025 Financial Results Full year 2025 total revenue was $40.5 million, up 7% year-over-year and in line with guidance Fourth quarter 2025 total revenue was $10.0 million, up 8% over the same quarter prior year Company provides 2026 revenue guidance of $42-44 million HOLLISTER, Calif., February 26, 2026 – Alpha Teknova, Inc. ("Teknova" or the "Company") (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commerc ...
Braemar Hotels & Resorts(BHR) - 2025 Q4 - Annual Results
2026-02-26 21:08
DALLAS – February 26, 2026 – Braemar Hotels & Resorts Inc. (NYSE: BHR) ("Braemar" or the "Company") today reported financial results and performance measures for the fourth quarter and full year ended December 31, 2025. The comparable performance measurements for Occupancy, Average Daily Rate (ADR), Revenue Per Available Room (RevPAR), and Hotel EBITDA assume each of the hotel properties in the Company's hotel portfolio as of December 31, 2025 was owned as of the beginning of each of the periods presented. ...
Northwest Pipe(NWPX) - 2025 Q4 - Annual Report
2026-02-26 21:08
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-27140 NWPX INFRASTRUCTURE, INC. (Exact name of registrant as specified in its charter) Oregon 93-0557988 State or ot ...
Dell Technologies(DELL) - 2026 Q4 - Annual Results
2026-02-26 21:08
Exhibit 99.1 "FY26 was a defining year in our company's history, with record full-year revenue of $113.5 billion, record EPS, and record cash generation," said Jeff Clarke, vice chairman and chief operating officer, Dell Technologies. "The AI opportunity is transforming our company. We closed more than $64 billion in AI- optimized server orders, shipped more than $25 billion throughout the year, and are entering FY27 with record backlog of $43 billion — powerful proof that our engineering leadership and dif ...